Opendata, web and dolomites

DigiPharm SIGNED

Value-based Healthcare Platform Secured with Blockchain Technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DigiPharm project word cloud

Explore the words cloud of the DigiPharm project. It provides you a very rough idea of what is the project "DigiPharm" about.

pakistani    conventional    determined    resistance    raised    professionals    inadequate    spend    healthcare    755m    health    winning    applies    validate    outcomes    digipharm    disruptive    accelerate    cryptocurrency    team    pricing    award    performance    ceo    dph    mitigate    substantial    viability    total    confidentiality    negotiation    un    entry    frauds    update    payments    service    continued    technologies    cefact    ten    transition    11m    model    people    asses    business    national    whom    incentive    price    software    shift    18    company    errors    area    burden    sme    cagr    grant    uk    expert    2022    stakeholders    initial    2019    headed    launch    patient    ahmed    barriers    pressure    dubai    admin    hindered    roche    blockchain    platform    market    commercialization    revenue    treatment    risk    contracting    eliminates    abdulla    oman    solution    infrastructure    2026    plan    switch    operation    competes    administrative    corporation    contract    introduction    government    eases    smart    full    reluctance    drastically    tool    economist   

Project "DigiPharm" data sheet

The following table provides information about the project.

Coordinator
DIGIPHARM SWITZERLAND GMBH 

Organization address
address: HELVETIERSTRASSE 5
city: THERWIL
postcode: 4106
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIGIPHARM SWITZERLAND GMBH CH (THERWIL) coordinator 50˙000.00

Map

 Project objective

The healthcare is under pressure to spend the resources efficiently and to shift to payments by using a 'value-based' approach, where the price is determined by treatment performance and patient outcomes. However, the transition is hindered by the inadequate infrastructure, the pricing confidentiality issues, and the resistance of some stakeholders against the change. DigiPharm aims to accelerate the value-based healthcare transition with a blockchain-based smart-contracting solution and a highly disruptive business model. The solution, the award-winning DigiPharm platform drastically eases the administrative burden, eliminates errors, and potential frauds in admin operation. As a new element in healthcare, DigiPharm has introduced a cryptocurrency (DPH), as a part of an incentive system. Within the total healthcare market, DigiPharm competes in the healthcare contract management software market that will reach $755M in 2019 with CAGR of 18% in the next years. The solution has raised interest from the UK National Health Service, Roche corporation, the Oman and Dubai Health Authorities, and the Pakistani Government, with whom the company is in negotiation to test the platform. The company would like to launch the full solution in 2022 with a revenue target of €11M by 2026, although they face substantial entry barriers, such as the reluctance to switch from conventional methods and the continued funding need. In order to mitigate the risk of market introduction, Digipharm applies for the SME Tool phase 1 grant to validate DigiPharm’s business viability, asses the further technical development needs, and the update our initial commercialization plan. Currently, ten people are involved in the project development, headed by Ahmed Abdulla, CEO, health economist, an expert at UN/CEFACT, supported by a team of professionals both from the business development area and the value-based healthcare technologies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIGIPHARM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIGIPHARM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More